Skip to main content

sovihep D

sovihep D

Description

The active substance is Sofosbuvir and Daclatasvir (sovihep d tablet), which is an inhibitor of the NS5A protein required for the synthesis of HCV.

The main purpose of the sovihep d is antiviral therapy. It is active in the fight against viral hepatitis C (genotypes 1, 2, 3, 4).

The essence of the impact is to block the development of HCV and its spread in the body of the carrier.

HCV exists in different forms known as genotypes.

Genotype 1 is the most common type of HCV genotype and sovihep d tablet is also the most difficult to treat using other treatments.

Mechanism of Action:

DCV is an HCV NS5A replication complex inhibitor.

This NS5A sovihep d  viral protein has enzymatic activity that is essential for HCV RNA replication and assembly.

In replication it appears to play a role in the formation of a membranous web along with viral protein NS4B, and this web provides a platform for replication.
The NS5A protein is composed of 3 domains;

Domains I and II are essential for HCV replication while the domain III seems to help the vision assembly.

The NS5A inhibitors have high antiviral sovihep d tablet potency but lower barrier to resistance development.

DCV acts as an NS5A inhibitor by binding within the first 100 amino acids of the amino terminus (i.e. domain 1) of the protein.

DCV results rapidly in serum HCV sovihep d  RNA drop by 2 logs within the first 6 h of administration, followed by a slower phase of decline, suggesting that it blocks vision assembly and release as well as viral RNA synthesis.
Dosage and administration

sovihep d tablet is given as a 60 mg oral dose once per day with or without food.

sovihep d should be administered at 60 mg/day or at 30 mg/day when a reduced dose is warranted.

Finally, sovihep d tablet dosage modification is not required in patients with liver failure Child-Pugh (CP) B or C, in the elderly or in patients with renal or hepatic impairment.

Side Effects

•Headache

•Unusual tiredness

•Nausea and Vomiting

• Diarrhea

• Anemia

•Severe skin rash and hives

•Dizziness

•Sleep disturbances

•Shortness of breath

•Chest pain or discomfort

•Mental confusion

•Memory problems



Warning and Contradictions:

sovihep d tablet 60 Tablet may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Adverse Events:

The most commonly reported AEs were (≥5%): headache (14%), fatigue (14%), nausea (8%), and diarrhea (5%)

CONTACT US :

EMAIL ID : millionhealthpharmaceuticals@gmail.com

PHONE NO : +91-9940472902

WEBSITE URL : https://pillsbag.com/products/sovihep-d

KEYWORDS : sovihep d,sovihep d tablet, sovihep d price in India



Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Ikgdar 500 mg|Rituximab injection |uses,dose,side effects,price India

IKGDAR 500MG DESCRIPTION: Ikgdar 500mg is a anticancer medicine which prevents the growth and spread of cancer cells in the body. Ikgdar 500mg injection also indicated for the treatment of Non- Hodgkins lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment. Ikgdar 500mg with steroid regimen combination is given for the treatment of some rare disorders which cause blood vessels and other tissues inflammation in the body. INDICATION: Ikgdar 500mg injection and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC). Ikgdar 500mg injection is also used with methotrexate (Otrexup, Rasuvo, Xatmep, others) for the treatment rheumatoid arthritis symptoms in adults that have been already treated with a some type of regimen known as tumor necrosis...
Post a Comment
Read more

Ikgdar 100 mg|Rituximab injection |uses,dose,side effects,price India

IKGDAR -100MG DESCRIPTION Ikgdar 100mg is a anticancer medicine which prevents the growth and spread of cancer cells in the body. Ikgdar 100mg injection also indicated for the treatment of Non- Hodgkins lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment. Ikgdar 100mg with steroid regimen combination is given for the treatment of some rare disorders which cause blood vessels and other tissues inflammation in the body. INDICATION Ikgdar 100mg injection and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC). Ikgdar 100mg injection is also used with methotrexate (Otrexup, Rasuvo, Xatmep, others) for the treatment rheumatoid arthritis symptoms in adults that have been already treated with a some type of regimen known as tumor necrosi...
Post a Comment
Read more

Prolia 60mg injection | Denosumab | MHP

PROLIA 60MG DESCRIPTION: Prolia 60mg  is a human monoclonal antibody for the treatment of osteoporosis, treatment-persuaded bone loss, metastases to bone, and giant cell tumor of bone. Prolia 60mg contraindicated in people with low blood calcium levels. Prolia 60mg injection is prescription drug which is used under the guidance of medical oncologist. INDICATION: • Indicated for treatment of osteoporosis at high risk postmenopausal women with (end of menopause/ change of life), whose have serious problem of fractures raised or who failed to other medication of osteoporosis. • Indicated for treatment of Breast cancer in women whose taking certain treatment which make severe their risk of fractures and bone loss in men with prostate cancer. • Indicated for treatment in adults and some adolescents with giant cell tumor of bone which cannot treat with surgery / surgery is not possible is treated with Prolia 60mg injection . MECHANISM OF ACTION: Denosumab mechanism by aim...
Post a Comment
Read more